Category Archives:

By David Milliken LONDON (Reuters) -British manufacturers are investing the least in new equipment relative to their sales since 2017, according to a report from trade body Make UK, which urged the go...

TOKYO (Reuters) -A leading indicator of Japan's service-sector inflation perked up for the second straight month in September, data showed on Monday, backing up the central bank's view that rising lab...

(Reuters) -HSBC Holdings said on Monday it will recognise a provision of $1.1 billion in its third-quarter results after a Luxembourg court ruling in a long-running lawsuit tied to the Bernard Madoff ...

(Reuters) -Australia's Larvotto Resources said on Monday it had rejected a non-binding indicative offer received last week from United States Antimony Corporation, valuing the miner at about A$722.9 m...

(Reuters) -Australia's competition regulator on Monday sued Microsoft, accusing it of misleading customers into paying higher prices for Microsoft 365 subscriptions after bundling its AI assistant Cop...

By Idrees Ali and David Shepardson WASHINGTON (Reuters) -U.S. airports reported more than 20 incidents of air traffic controller shortages on Saturday, Transportation Secretary Sean Duffy said, in the...

By Kate Abnett BRUSSELS (Reuters) -European Union countries are negotiating proposals to give industries a more flexible path to meeting climate goals, a draft EU document showed, as the bloc attempts...

(Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash. Avidity stockholders will receive $72 per share in cash, re...

By Dan Catchpole (Reuters) -Striking workers at Boeing Defense in the St. Louis area rejected the company's latest contract proposal on Sunday, sending a strike that has already delayed delivery of fi...

(Reuters) -Swiss drugmaker Novartis AG is close to acquiring U.S. biotech Avidity Biosciences for over $70 per share, Bloomberg News reported on Sunday, citing a person familiar with the matter. Reute...